三维斑点追踪参数预测MYH7突变肥厚型心肌病预后
该回顾性研究纳入43例携带MYH7突变的肥厚型心肌病患者,采用三维斑点追踪成像评估心功能并随访不良心血管事件。多因素Cox回归显示三维左心室整体纵向应变(3D-GLS)是独立预测因素(HR=0.814,95%CI 0.663-0.999,P=0.049),3D-GLS≤13.67%提示事件风险显著增加。
要点
- 3D-GLS降低是MYH7突变HCM患者不良心血管事件的独立预测因素。
- 3D-GLS≤13.67%的患者不良事件风险显著增加,敏感度86%、特异度69%。
- 终点事件组晕厥比例、5年SCD风险评分及LAVI较高,3D-GLS较低。
核心结论
- 3D-STI指标3D-GLS可用于预测携带MYH7基因突变的肥厚型心肌病患者的不良心血管事件。
研究设计与样本
- 回顾性研究,连续入选2014年10月至2016年10月单中心192例HCM患者经基因筛查,纳入43例携带MYH7突变的成人HCM患者,分终点事件组(n=13)和无终点事件组(n=30),随访至2019年1月。
主要发现
- 终点事件组较无终点事件组晕厥比例更高、5年SCD风险评分更高、LAVI更大、3D-GLS绝对值更低(均P<0.05)。
- 多因素Cox回归显示3D-GLS是独立预测因素(HR=0.814,95%CI 0.663-0.999,P=0.049)。
- 3D-GLS≤13.67%预测不良事件的AUC=0.753(95%CI 0.558-0.948,P<0.05),敏感度86%,特异度69%。
- Kaplan-Meier分析显示3D-GLS≤13.67%的患者无终点事件生存率显著低于3D-GLS>13.67%者(P<0.05)。
关键数值与推荐
- 3D-GLS≤13.67%为预测不良心血管事件的截断值(AUC=0.753,95%CI 0.558-0.948,敏感度86%,特异度69%)。
临床怎么用
- 对MYH7突变HCM患者可考虑行3D-STI检测3D-GLS,若≤13.67%提示不良事件风险增高,需加强随访管理。
局限性
- 回顾性单中心研究,样本量较小(43例),事件数少(13例),结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the cardiac functional changes in hypertrophic cardiomyopathy(HCM) patients with β-myosin heavy chain gene (MYH7) mutations by three-dimensional (3D) speckle tracking imaging(3D-STI) and conventional echocardiography modalities, and then to explore the potential predictors of adverse cardiovascular events in these patients. Methods: A consecutive series of 192 HCM patients admitted in our center from October 2014 to October 2016 were genetically screened to identify MYH7 mutations in this retrospective study. A total of 43 HCM patients with MYH7 mutations were enrolled. The patients were divided into events group(n=13) and no event group(n=30) according to the presence or absence of adverse cardiovascular events(primary and secondary endpoints). All patients were followed up to January 2019 after comprehensive evaluation of 3D-STI, two-dimensional and Doppler echocardiography. The adverse cardiovascular events were recorded. Results: The median follow up time was 1 012 (812, 1 330) days. During follow-up, 13 patients (30.2%) reached endpoints: 6 cases of the primary endpoints(2 cases of sudden cardiac death(SCD), 3 cases of survival after defibrillation, and 1 case of appropriate implantable cardioverter-defibrillator(ICD) discharge); 7 cases of the second endpoints(5 cases of heart failure hospitalization, 1 case of syncope and cardioversion due to supraventricular tachycardia, and 1 case of end-stage HCM). Patients with adverse cardiovascular events had higher prevalence of syncope and risk of SCD, enlarged left atrial volume index(LAVI) and reduced 3D left ventricular global longitudinal train (3D-GLS), as compared to those without adverse events(all P<0.05). The multivariate Cox regression analysis showed that reduced 3D-GLS(HR=0.814, 95%CI 0.663-0.999, P=0.049) was an independent predictor for adverse cardiovascular events. The cutoff value of 3D-GLS≤13.67% was linked with significantly increased risk of adverse cardiovascular events in this patient cohort(AUC=0.753, 95%CI 0.558-0.948, sensitivity 86%, specificity 69%, P<0.05). The Kaplan-Meier analysis indicated that the patients with the 3D-GLS≤ 13.67% faced higher risk of death than those with 3D-GLS>13.67%. Conclusion: 3D-GLS is useful on predicting adverse cardiovascular events in HCM patients with MYH7 mutations. 目的: 采用三维斑点追踪(3D-STI)技术联合二维和多普勒超声对携带β-肌球蛋白重链基因(MYH7)基因突变的肥厚型心肌病(HCM)患者心功能特征进行全面评估,以期找到可预测此类患者不良心血管事件的超声指标。 方法: 该研究为回顾性研究。连续入选2014年10月至2016年10月在西京医院肥厚型心肌病诊治中心就诊的携带MYH7基因突变的成人HCM患者43例,根据有无终点事件发生分为2组,即终点事件组(n=13)和无终点事件组(n=30)。收集入选患者的一般临床资料、超声心动图检测结果及随访结果,记录终点事件的发生情况。终点事件:一级终点事件包括心脏性猝死(SCD),心脏骤停抢救存活或植入埋藏式心脏除颤器(ICD)适当放电;二级终点事件包括急性心梗,因心力衰竭住院,血栓栓塞,室上性心律失常致血流动力学不稳定,终末期HCM。 结果: 43例患者均完成随访,随访时间1 012(812,1 330)d。13例(30.2%)患者发生终点事件,其中6例(14.0%)发生一级终点事件(SCD 2例、心脏骤停抢救存活3例、ICD适当放电1例),7例(16.3%)发生二级终点事件(因心力衰竭住院5例、室上性心动过速致晕厥复律1例、终末期HCM 1例)。与无终点事件组比较,终点事件组患者5年SCD风险评分较高(P<0.05),发生晕厥的患者比例较高(P<0.05),左心房容积指数(LAVI)较大(P<0.05),左心室三维整体纵向应变(GLS)绝对值较低(P<0.05)。校正年龄、性别后多因素Cox回归分析结果显示,GLS是携带MYH7基因突变的HCM患者发生不良心血管事件的独立预测因素(HR=0.814,95%CI 0.663~0.999,P=0.049)。受试者工作特征(ROC)绝对值曲线评估结果显示,GLS绝对值≤13.67%的患者更易发生不良心血管事件(AUC=0.753,95%CI 0.558~0.948,P<0.05),敏感度为86%,特异度为69%。Kaplan-Meier生存曲线结果进一步显示,GLS绝对值≤13.67%的HCM患者无终点事件生存率明显低于GLS绝对值>13.67%的患者(P<0.05)。 结论: 3D-STI指标GLS可作为携带MYH7基因突变的HCM患者不良心血管事件的预测指标。.
引用
- Zhao J, Wang J, Liu LW, et al. [The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32370479. doi:10.3760/cma.j.cn112148-20190802-00451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。